Necrostatin-1 Ameliorates Peripheral Nerve Injury-Induced Neuropathic Pain by Inhibiting the RIP1/RIP3 Pathway
Necrostatin-1 is an inhibitor of necroptosis, a form of programmed cell death that has been reported to be involved in various neurological diseases. Presently, the role of necroptosis in neuropathic pain induced by peripheral nerve injury is still unclear. This study was focused on investigating th...
Main Authors: | Ying-Xia Liang, Nan-Nan Wang, Zhi-Yu Zhang, Zhao-Dong Juan, Can Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fncel.2019.00211/full |
Similar Items
-
RIP3‐mediated necroptosis increases neuropathic pain via microglia activation: necrostatin‐1 has therapeutic potential
by: Ping Fang, et al.
Published: (2021-10-01) -
Necrostatin-1: a promising compound for neurological disorders
by: Ke-qian Chen, et al.
Published: (2024-06-01) -
GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma
by: Mengyuan Liu, et al.
Published: (2022-10-01) -
Effect of necrostatin-1 on sciatic nerve crush injury in rat models
by: Chen Yu, et al.
Published: (2023-01-01) -
RIP1 and RIP3 mediate hemin-induced cell death in HT22 hippocampal neuronal cells
by: Su X, et al.
Published: (2018-11-01)